Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−13.94 USD
−10.83 M USD
0.00 USD
1.02 M
About Phio Pharmaceuticals Corp.
Sector
Industry
CEO
Robert J. Bitterman
Website
Headquarters
Marlborough
Founded
2011
FIGI
BBG0024FKD97
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PHIO is 2.79 USD — it has increased by 7.35% in the past 24 hours. Watch Phio Pharmaceuticals Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Phio Pharmaceuticals Corp. stocks are traded under the ticker PHIO.
PHIO stock has risen by 13.62% compared to the previous week, the month change is a −2.01% fall, over the last year Phio Pharmaceuticals Corp. has showed a −71.30% decrease.
PHIO reached its all-time high on Mar 14, 2013 with the price of 6,379,560.00 USD, and its all-time low was 2.17 USD and was reached on Nov 15, 2024. View more price dynamics on PHIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PHIO stock is 7.33% volatile and has beta coefficient of 2.16. Track Phio Pharmaceuticals Corp. stock price on the chart and check out the list of the most volatile stocks — is Phio Pharmaceuticals Corp. there?
Today Phio Pharmaceuticals Corp. has the market capitalization of 3.08 M, it has increased by 14.48% over the last week.
Yes, you can track Phio Pharmaceuticals Corp. financials in yearly and quarterly reports right on TradingView.
Phio Pharmaceuticals Corp. is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
PHIO earnings for the last quarter are −1.54 USD per share, whereas the estimation was −4.14 USD resulting in a 62.80% surprise. The estimated earnings for the next quarter are −3.60 USD per share. See more details about Phio Pharmaceuticals Corp. earnings.
PHIO net income for the last quarter is −1.52 M USD, while the quarter before that showed −1.85 M USD of net income which accounts for 17.44% change. Track more Phio Pharmaceuticals Corp. financial stats to get the full picture.
No, PHIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 3, 2024, the company has 9.00 employees. See our rating of the largest employees — is Phio Pharmaceuticals Corp. on this list?
Like other stocks, PHIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Phio Pharmaceuticals Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Phio Pharmaceuticals Corp. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Phio Pharmaceuticals Corp. stock shows the sell signal. See more of Phio Pharmaceuticals Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.